Acyclovir dose for suppressive therapy

Suppressive therapy with acyclovir, famciclovir, or valacyclovir to a high-dose suppressive valacyclovir group (1,000 mg bid) in. ART

Suppressive therapy is not adequate for preventing transmission. Compared with no medication, all doses of acyclovir and valacyclovir

The acyclovir dose when used as suppressive therapy is 400 mg Acyclovir prophylaxis of HSV infections is of clinical value in severely immunocompromised patients

High-dose valacyclovir suppressive therapy results in greater reduction in plasma HIV-1 levels compared to standard dose acyclovir suppression

Acyclovir, valacyclovir, and famciclovir are effective for suppressive and episodic therapy. Valacyclovir is the prodrug of acyclovir, and has improved oral bioavailability, with decreased dosing frequency, compared to acyclovir.

The optimal total daily dose of suppressive acyclovir therapy is 800 mg. Recommended doses for adults, adolescents, and pregnant women

cy of acyclovir-resistance of the virus population isolated directly from lesions of genital herpes. This finding suggests that long-term, low-dose acyclovir suppressive therapy for Antiviral Chemistry Chemotherapy 3 239 Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of

by R Patel Cited by 169The optimal total daily dose of suppressive aciclovir therapy Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.

Acyclovir, valacyclovir, and famciclovir are effective for suppressive and episodic therapy. Valacyclovir is the prodrug of acyclovir, and has